ArticleSpringerPlus2013

Trade-offs in quality of life and survival with chemotherapy for advanced breast cancer: mature results of a randomized trial comparing single-agent mitoxantrone with combination cyclophosphamide, methotrexate, 5-fluorouracil and prednisone.

Chee Khoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.